Evidence map›Paper›PMID 34046425›Full record

ArticleFrontiers in molecular biosciences2021

Cannabidiol Modulates Mitochondrial Redox and Dynamics in MCF7 Cancer Cells: A Study Using Fluorescence Lifetime Imaging Microscopy of NAD(P)H.

Rhys Richard Mould, Stanley W Botchway, James R C Parkinson, Elizabeth Louise Thomas, Geoffrey W Guy, Jimmy D Bell, Alistair V W Nunn

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Rhys Richard MouldResearch Centre for Optimal Health, School of Life Sciences, University of Westminster, London, United Kingdom.
Stanley W BotchwayCentral Laser Facility, Science and Technology Facilities Council, UKRI, Rutherford Appleton Laboratory, Harwell Campus, Oxford, United Kingdom.
James R C ParkinsonResearch Centre for Optimal Health, School of Life Sciences, University of Westminster, London, United Kingdom.
Elizabeth Louise ThomasResearch Centre for Optimal Health, School of Life Sciences, University of Westminster, London, United Kingdom.
Geoffrey W GuyGW Pharmaceuticals, Salisbury, United Kingdom.
Jimmy D BellResearch Centre for Optimal Health, School of Life Sciences, University of Westminster, London, United Kingdom.
Alistair V W NunnResearch Centre for Optimal Health, School of Life Sciences, University of Westminster, London, United Kingdom.
University of Westminster · GBGW Pharmaceuticals (United Kingdom) · GBRutherford Appleton Laboratory · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cannabinoid, cannabidiol (CBD), is part of the plant's natural defense system that when given to animals has many useful medicinal properties, including activity against cancer cells, modulation of the immune system, and efficacy in epilepsy. Although there is no consensus on its precise mode of action as it affects many cellular targets, CBD does appear to influence mitochondrial function. This would suggest that there is a cross-kingdom ability to modulate stress resistance systems that enhance homeostasis. As NAD(P)H autofluorescence can be used as both a metabolic sensor and mitochondrial imaging modality, we assessed the potential of this technique to study the

Indexed as

cannabidiolFLIMimagingmitochondrial dynamicsmultiphotonNADH autofluorescenceredox

Identifiers

PMID34046425
PMCPMC8144465
OpenAlexW3161727693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.